SecSonar.com

Bausch Health Companies Inc. (BHC)

Bausch Health Companies Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Bausch Health Companies Inc. (BHC) is a Drug Manufacturers - Specialty & Generic company based in CA with a market capitalization of $2B. Revenue grew 8.5% year-over-year and the company generated $1B in free cash flow. This page tracks BHC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CA · 20.7K employees · IPO Mar 29, 1994

Valuation

Valuation & price

$5.51 · as of May 26, 2026 · -33.9% vs 52w high

12.9

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$8.34$6.50$4.67Jul 25Dec 25Jul 26Jul 7, 25$6.87Jul 9, 25$6.59Jul 11, 25$6.42Jul 15, 25$6.42Jul 17, 25$6.48Jul 21, 25$6.32Jul 23, 25$6.65Jul 25, 25$6.77Jul 29, 25$6.82Jul 31, 25$5.89Aug 4, 25$5.78Aug 6, 25$5.76Aug 11, 25$6.66Aug 13, 25$7.17Aug 15, 25$8.34Aug 19, 25$7.79Aug 21, 25$7.50Aug 25, 25$7.30Aug 27, 25$7.27Aug 29, 25$7.42Sep 3, 25$7.35Sep 5, 25$7.35Sep 9, 25$7.21Sep 11, 25$7.25Sep 16, 25$6.78Sep 18, 25$6.89Sep 22, 25$6.81Sep 24, 25$6.65Sep 26, 25$6.48Sep 30, 25$6.45Oct 2, 25$6.55Oct 6, 25$6.47Oct 8, 25$6.34Oct 10, 25$6.05Oct 14, 25$6.11Oct 16, 25$6.01Oct 21, 25$6.16Oct 23, 25$6.38Oct 27, 25$6.20Oct 29, 25$5.90Oct 31, 25$7.02Nov 4, 25$6.74Nov 6, 25$6.69Nov 10, 25$6.40Nov 12, 25$6.94Nov 14, 25$6.28Nov 18, 25$6.18Nov 20, 25$6.00Nov 25, 25$6.32Nov 28, 25$6.35Dec 2, 25$6.90Dec 4, 25$7.38Dec 8, 25$6.82Dec 10, 25$6.82Dec 12, 25$6.92Dec 16, 25$6.93Dec 18, 25$6.82Dec 22, 25$6.99Dec 24, 25$7.18Dec 29, 25$7.13Jan 2, 26$7.21Jan 6, 26$7.63Jan 8, 26$7.77Jan 12, 26$7.49Jan 14, 26$7.45Jan 16, 26$6.98Jan 21, 26$6.65Jan 23, 26$5.91Jan 27, 26$5.72Jan 29, 26$5.59Feb 2, 26$5.76Feb 4, 26$5.66Feb 9, 26$5.98Feb 11, 26$6.08Feb 13, 26$5.99Feb 18, 26$6.19Feb 20, 26$6.13Feb 24, 26$6.02Feb 26, 26$6.04Mar 2, 26$5.95Mar 4, 26$5.63Mar 6, 26$5.38Mar 10, 26$5.40Mar 12, 26$5.05Mar 17, 26$5.18Mar 19, 26$5.03Mar 23, 26$5.10Mar 25, 26$5.08Mar 27, 26$5.02Mar 31, 26$5.40Apr 2, 26$5.35Apr 7, 26$5.26Apr 9, 26$5.39Apr 13, 26$5.72Apr 15, 26$5.74Apr 17, 26$5.90Apr 22, 26$5.68Apr 24, 26$5.63Apr 28, 26$5.67Apr 30, 26$5.72May 4, 26$5.53May 6, 26$5.65May 8, 26$5.75May 12, 26$5.41May 14, 26$5.45May 18, 26$5.34May 20, 26$5.50May 22, 26$5.47May 28, 26$5.41Jun 1, 26$5.31Jun 3, 26$4.95Jun 5, 26$5.37Jun 9, 26$5.17Jun 11, 26$5.16Jun 15, 26$4.99Jun 17, 26$4.76Jun 22, 26$4.67Jun 24, 26$4.99Jun 26, 26$4.76Jul 2, 26$4.90
$4.6752-week range$8.34
Loading valuation history…

Fundamentals

Key fundamentals

$2B

Market cap

8.5%

Revenue growth (YoY)

60.9%

Gross margin

$1B

Free cash flow (USD)

$19.9B

Net debt

0.8%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$9.7BFY 2017$8.7BFY 2018$8.4BFY 2019$8.6BFY 2020$8.0BFY 2021$8.4BFY 2022$8.1BFY 2023$8.8BFY 2024$9.6BFY 2025$10.4B
$9.7B$10.4B

Free cash flow by year

2016 → 2025

FY 2016$1.8BFY 2017$2.0BFY 2018$1.3BFY 2019$1.2BFY 2020$802.0MFY 2021$1.1BFY 2022$-996.0MFY 2023$760.0MFY 2024$1.3BFY 2025$1.0B
$1.8B$1B

Gross margin by year

2021 → 2025

FY 202171.6%FY 202270.9%FY 202370.8%FY 202471.1%FY 202560.9%
71.6%60.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBoard ResignationJul 1, 2026Filing
  • Insider sellInsider Sell $133K · 10b5-1 PlanLee Frank D. · Director · $132.8KMay 20, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 19, 2026Filing
  • Quarterly report10-Q FiledApr 30, 2026Filing
  • 8-K eventEarnings ReleaseApr 29, 2026Filing

Questions

Frequently asked questions

What is Bausch Health Companies Inc.'s market cap?

Bausch Health Companies Inc. (BHC) has a market capitalization of $2B.

What is BHC's P/E ratio?

BHC trades at a price-to-earnings ratio of 12.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

Are insiders buying BHC stock?

SEC Form 4 filings show no open-market insider buys at Bausch Health Companies Inc. in the last 90 days (1 sell).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

HCM

HUTCHMED (China) Limited

$2B

ANIP

ANI Pharmaceuticals, Inc.

$1.8B

PRGO

Perrigo Company plc

$1.6B

HROW

Harrow Health, Inc.

$1.3B

SUPN

Supernus Pharmaceuticals, Inc.

$2.7B

PAHC

Phibro Animal Health Corporation

$1.3B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.